Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure 
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
Bain Capital Moves to Acquire Majority Stake in Echo Marketing 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
LAFAYETTE, La., Oct. 20, 2017 -- LHC Group, Inc. (NASDAQ:LHCG) announced details for the release of its results for the third quarter and nine months ended September 30, 2017.
LHC Group plans to issue its earnings release for the third quarter of 2017 before the market opens on Monday, November 6, 2017, and will host a conference call on that same day at 11:00 a.m. Eastern time. The Company has scheduled the timing of the call to be able to discuss CMS’ release of the Final FY 2018 Home Health Prospective Payment System Rate Update, which is expected on or around Thursday, November 2, 2017. The toll-free number to call for this interactive teleconference is (866) 393‑1608 (international callers: (973) 890-8327). A telephonic replay of the conference call will be available through midnight on Monday, November 13, 2017, by dialing (855) 859‑2056 (international callers: (404) 537-3406) and entering confirmation number 96827521.
A live broadcast of LHC Group’s conference call will be available under the Investor Relations section of the Company’s website, www.LHCGroup.com. A one-year online replay will be available approximately an hour following the conclusion of the live broadcast.
About LHC Group, Inc.
LHC Group, Inc. is a national provider of non-acute healthcare services, providing quality, cost‑effective healthcare to patients primarily within the comfort and privacy of their home or place of residence. LHC Group provides a comprehensive array of healthcare services through home health, hospice, community-based services agencies and facility-based services. LHC Group operates 320 home health services locations, 92 hospice locations, 12 community-based service locations and 11 long-term acute care hospitals (LTACHs).
Contact: Eric Elliott Senior Vice President of Finance (337) 233-1307 [email protected]
